Suppression of PI(3,4,5)P3 production is a key determinant of B cell anergy

Anergy is a critical physiologic mechanism to censor self-reactive B cells. However, a biochemical understanding of how anergy is achieved and maintained is lacking. Herein, we investigated the role of the phosphoinositide 3-kinase (PI3K) lipid product PI(3,4,5)P 3 in B cell anergy. We found reduced...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 31; no. 5; pp. 749 - 760
Main Authors Browne, Cecille D., Del Nagro, Christopher J., Cato, Matthew H., Dengler, Hart S., Rickert, Robert C.
Format Journal Article
LanguageEnglish
Published 05.11.2009
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anergy is a critical physiologic mechanism to censor self-reactive B cells. However, a biochemical understanding of how anergy is achieved and maintained is lacking. Herein, we investigated the role of the phosphoinositide 3-kinase (PI3K) lipid product PI(3,4,5)P 3 in B cell anergy. We found reduced generation of PI(3,4,5)P 3 in anergic B cells, which was attributable to reduced phosphorylation of the PI3K membrane adaptor CD19, as well as increased expression of the inositol phosphatase PTEN. Sustained production of PI(3,4,5)P 3 in B cells, achieved through conditional deletion of Pten, resulted in failed tolerance induction and abundant autoantibody production. In contrast to wildtype immature B cells, BCR engagement of PTEN-deficient immature B cells resulted in activation and proliferation, indicating a central defect in early B cell responsiveness. These findings establish repression of the PI3K signaling pathway as a necessary condition to avert the generation, activation and persistence of self-reactive B cells.
Bibliography:These authors contributed equally to this work.
Present address: Roche Palo Alto LLC, Inflammation Discovery, 3431 Hill view Avenue, Palo Alto, CA 94304 USA
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2009.08.026